| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-11 22:30:04 UTC |
|---|
| Updated at | 2024-09-11 22:30:05 UTC |
|---|
| NP-MRD ID | NP0339570 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | NAD+ |
|---|
| Description | NAD+ belongs to the class of organic compounds known as (5'->5')-dinucleotides. These are dinucleotides where the two bases are connected via a (5'->5')-phosphodiester linkage. NAD+ was first documented in 2024 (PMID: 39299659). Based on a literature review a small amount of articles have been published on NAD+ (PMID: 39289323) (PMID: 39286797). |
|---|
| Structure | NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O InChI=1/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20-,21-/s2 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C21H27N7O14P2 |
|---|
| Average Mass | 663.4300 Da |
|---|
| Monoisotopic Mass | 663.10912 Da |
|---|
| IUPAC Name | 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1lambda5-pyridin-1-ylium |
|---|
| Traditional Name | 1-[(2R,3R,4S,5R)-5-[({[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl phosphonato}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1lambda5-pyridin-1-ylium |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O |
|---|
| InChI Identifier | InChI=1/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20-,21-/s2 |
|---|
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | This compound belongs to the class of organic compounds known as (5'->5')-dinucleotides. These are dinucleotides where the two bases are connected via a (5'->5')-phosphodiester linkage. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Nucleosides, nucleotides, and analogues |
|---|
| Class | (5'->5')-dinucleotides |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | (5'->5')-dinucleotides |
|---|
| Alternative Parents | |
|---|
| Substituents | - (5'->5')-dinucleotide
- Purine nucleotide sugar
- Purine ribonucleoside diphosphate
- Purine ribonucleoside monophosphate
- Nicotinamide-nucleotide
- Pyridine nucleotide
- Pentose-5-phosphate
- Pentose phosphate
- Glycosyl compound
- N-glycosyl compound
- 6-aminopurine
- Monosaccharide phosphate
- Organic pyrophosphate
- Purine
- Imidazopyrimidine
- Nicotinamide
- Monoalkyl phosphate
- Aminopyrimidine
- Monosaccharide
- N-substituted imidazole
- Organic phosphoric acid derivative
- Imidolactam
- Phosphoric acid ester
- Alkyl phosphate
- Pyrimidine
- Pyridinium
- Pyridine
- Tetrahydrofuran
- Azole
- Imidazole
- Heteroaromatic compound
- Secondary alcohol
- Carboximidic acid derivative
- Carboximidic acid
- Organoheterocyclic compound
- Oxacycle
- Azacycle
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxide
- Organic zwitterion
- Primary amine
- Organonitrogen compound
- Amine
- Organic nitrogen compound
- Alcohol
- Organic oxygen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Sun Y, Ding S, Shen F, Yang X, Sun W, Wan J: Employ machine learning to identify NAD+ metabolism-related diagnostic markers for ischemic stroke and develop a diagnostic model. Exp Gerontol. 2024 Oct 15;196:112584. doi: 10.1016/j.exger.2024.112584. Epub 2024 Sep 19. [PubMed:39299659 ]
- Aggarwal S, Rastogi A, Maiwall R, Sevak JK, Yadav V, Maras J, Thomas SS, Kale PR, Pamecha V, Perumal N, Trehanpati N, Ramakrishna G: Palmitic acid causes hepatocyte inflammation by suppressing the BMAL1-NAD(+)-SIRT2 axis. J Physiol Biochem. 2024 Sep 18. doi: 10.1007/s13105-024-01042-x. [PubMed:39289323 ]
- Vijayan VV, Nair PG, Gujar S: Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy. Oncoimmunology. 2024 Sep 12;13(1):2400429. doi: 10.1080/2162402X.2024.2400429. eCollection 2024. [PubMed:39286797 ]
|
|---|